TITLE

BEAUTIFUL: no go for go slow with ivabradine?

PUB. DATE
January 2009
SOURCE
Heart;Jan2009, Vol. 95 Issue 2, p171
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the effectiveness of ivabradine, a heart-rate-lowering agent, in preventing cardiovascular death and mortality in patients with coronary heart disease and impaired systolic function. A BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary heart disease and left-ventricULar dysfunction) trial revealed that ivabradine was able to reduce the secondary end points of non-fatal myocardial infarction.
ACCESSION #
36168225

 

Related Articles

  • Reperfusion Therapy for Acute Myocardial Infarction: Which Strategy for Which Patient? Boersma, E.; Steyerberg, E.W.; van der Vlugt, M.J.; Simoons, M.L. // Drugs;Jul1998, Vol. 56 Issue 1, p31 

    Several modes of reperfusion therapy for evolving myocardial infarction (MI) have been developed, which differ in terms of effectiveness, complexity and costs. Reperfusion resources are often restricted by budgetary or logistical circumstances. To arrive at an equitable distribution of treatment...

  • Acute Coronary Syndrome: A Concise Summary for the Non-cardiologist. McFeely, James E. // Critical Care Alert;May2009, Vol. 17 Issue 2, p14 

    The article offers information on the management of the acute coronary syndrome of ST-elevation myocardial infarction (STEMI).

  • Treatment of Right Ventricular Infarction. Movahed, Assad // American Family Physician;10/15/1999, Vol. 60 Issue 6, p1640 

    Editorial. Discusses the treatment for right ventricular infarction. Occurrence of right ventricular infarction; Description of right ventricular infarction; Diagnosis of right ventricular infarction.

  • Heart Attack Treatment.  // HealthFacts;Feb2000, Vol. 25 Issue 2, p5 

    Provides information on the treatment for heart attack.

  • Differential Benefits and Outcomes of Tirofiban vs Abciximab for Acute Coronary Syndromes in Current Clinical Practice. Gowda, Manohar S.; Vacek, James L.; Lakkireddy, D.J.; Brosnahan, Kathleen; Beauchamp, Gary D. // Angiology;Mar/Apr2003, Vol. 54 Issue 2, p211 

    Little comparative data exist for glycoprotein IIb/IIIa inhibitors in acute coronary syndromes (ACS). Two hundred twenty-eight patients were studied: 114 received tirofiban (TI) and 114 received abciximab (AB) for either unstable angina (UA) or myocardial infarction (MI). All patients received...

  • Clopidogrel beneficial during acute phase of Ml; metoprolol has no overall effect.  // Formulary;May2005, Vol. 40 Issue 5, p162 

    Discusses a study which showed that clopidogrel reduces 28-day mortality in the treatment of patients with acute myocardial infarction (MI) when given on top of standard therapies, but metoprolol has no effect on inhospital mortality when given during the acute phase of MI. Findings of...

  • CODING FOR ACUTE MYOCARDIAL INFARCTION.  // For the Record (Great Valley Publishing Company, Inc.);8/1/2011, Vol. 23 Issue 14, p27 

    The article offers information on the acute myocardial infarction (AMI) coding in the U.S. It notes that AMI is identified to International Classification of Diseases (ICD)-9-Clinical Modification (CM) category 410 which is described as subendocardial, non-transmural, non-ST elevation myocardial...

  • AHA, ACC issue new guidelines for treatment of STEMI.  // Cardiology Today;Feb2013, Vol. 16 Issue 2, p21 

    The article discusses the guidelines issued by the American College of Cardiology (ACC) for the treatment of patients with ST-Segment Elevation Myocardial Infarction (STEMI).

  • National service framework for coronary heart disease: audit of English hospitals. Rhodes, Michelle; Newman, Christopher; Read, Susan // BMJ: British Medical Journal (International Edition);3/23/2002, Vol. 324 Issue 7339, p709 

    Reports on a study which audited the delivery of thrombolysis in all acute hospitals in England. National service framework for coronary heart disease which gives priority to reducing delays in the delivery of thrombolysis for acute myocardial infarction; Methods; Results; Indication of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics